US authorizes AstraZeneca's Evusheld for pre-exposure prevention of COVID-19

Dec 09, 2021

New Delhi [India], December 9 : AstraZeneca's Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in...